Chronic Lymphocytic Leukemia Clinical Trials
A listing of Chronic Lymphocytic Leukemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 299 clinical trials
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
, and venetoclax, given in combination as a treatment for CLL and/or SLL.
- 22 views
- 07 Oct, 2022
- 7 locations
Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL
This research study is studying a combination of drugs as a possible treatment for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The names of the study drugs
- 0 views
- 22 Aug, 2021
- 3 locations
Personalized Multi-peptide Vaccination in CLL Patients
The aim of this study is to evaluate the efficiency along with safety and toxicity of a personalizied multi-peptide vaccine in combination with the TLR1/2 ligand XS15 in CLL patients undergoing
- 0 views
- 18 Sep, 2021
- 1 location
Belimumab in Patients With Chronic Lymphocytic Leukemia (BeliVeR)
This study is a phase II trial of belimumab in combination with rituximab/venetoclax in patients with refractory or relapsed chronic lymphocytic leukemia (CLL). Treatment of CLL has drastically
- 0 views
- 25 Mar, 2022
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
This study will combine both T cells and antibodies in order to create a more effective treatment. The treatment tested in this study uses modified T-cells called Autologous T Lymphocyte Chimeric Antigen Receptor (ATLCAR) cells targeted against the kappa light chain antibody on cancer cells. For this study, the anti-kappa …
- 15 views
- 09 Dec, 2021
- 1 location
Acalabrutinib, Venetoclax, and Obinutuzumab for Initial Therapy of CLL (AVO)
This research study is evaluating the combination of three drugs - acalabrutinib, venetoclax, and obinutuzumab -- as a possible treatment for chronic lymphocytic leukemia (CLL). The drugs
- 233 views
- 19 Jun, 2022
- 3 locations
Copanlisib Plus Ibrutinib or Acalabrutinib in R/R CLL
six months for relapsed/refractory chronic lymphocytic leukemia (CLL). The names of the study drugs involved in this study are: Copanlisib Ibrutinib
- 0 views
- 02 Jun, 2022
- 1 location
Study to Evaluate the Safety and Preliminary Efficacy of Ibrutinib and Pembrolizumab in Patients With Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL)
been approved in the United States, Israel, and the European Union for use in adult patients with mantle cell lymphoma (MCL) and adult patients with chronic lymphocytic leukemia (CLL) who have received
- 88 views
- 04 Oct, 2022
- 1 location
Umbralisib Plus Ublituximab (U2) in Progressive CLL After Novel Therapy
This study evaluates the efficacy and safety of umbralisib and ublituximab (U2) as salvage therapy in patients with chronic lymphocytic leukemia (CLL) who have progressed either on a BTK
- 0 views
- 26 Apr, 2022
- 1 location
Selenious Yeast in CLL Patients w/o Indication of Chemotherapy
The purpose of this study is to evaluate the safety and effectiveness of Selenious Yeast Tablets in Chronic Lymphocytic Leukemia Patients without Indication of Chemotherapy
- 0 views
- 06 Dec, 2021
- 1 location